Advertisement
Advertisement

CUE

CUE logo

Cue Biopharma, Inc.

26.01
USD
Sponsored
-0.89
-3.31%
Jun 24, 15:59 UTC -4
Closed
exchange

Pre-Market

26.23

+0.22
+0.84%

CUE Earnings Reports

Positive Surprise Ratio

CUE beat 18 of 29 last estimates.

62%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$3.03M
/
-$1.70
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
+2.57%
/
-37.04%

Cue Biopharma, Inc. earnings per share and revenue

On May 08, 2026, CUE reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.11 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 2.52 million, with a --% difference.
Looking ahead to Q2 26, 2 analysts forecast an EPS of -1.70 USD, with revenue projected to reach 3.03 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Cue Biopharma, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 2 analysts, Cue Biopharma, Inc. is expected to report EPS of -$1.70 and revenue of $3.03M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement